← Leaderboards
Jan Novak
University Of Alabama At Birmingham
$14,197,925
Attributed
$22,579,385
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,579,385 · 10
By mechanism
R01$21,285,037 · 5
R21$1,202,053 · 3
R56$92,295 · 1
P01$0 · 1
Top collaborators
- Ali G Gharavi13 shared
- Todd Jason Green5 shared
- Matthew B Renfrow5 shared
- Francesco Scolari4 shared
- Jiri F Mestecky3 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Matthew B Renfrow$7,936,462
- John Franklin Kearney$21,145,276
- Jiri F Mestecky$6,392,348
- Colin Robert Reily$2,556,945
- Bruce A Julian$1,390,994
Others in their field
Top investigators on “Polysaccharides”
- Barton F Haynes · Duke University$271,280,523
- James C. Paulson · Scripps Research Institute$26,939,993
- George M Shaw · University Of Pennsylvania$26,084,324
- Arturo Casadevall · Johns Hopkins University$24,878,303
- Pamela J Bjorkman · California Institute Of Technology$23,198,758
- Ajit P Varki · University Of California San Diego$23,013,837
Research focus
PolysaccharidesGlomerulonephritisAntigen-Antibody ComplexMolecularDepositionGalactosePathogenesisComplexKidneyImmunoglobulin GSerumBaseEnd Stage Renal FailureIga1Immunoglobulin AGlycosylationImmuneCharacteristicsDefectDiagnosisProductionFutureEpitopesKidney Diseases
Grant awards (51)
Defining the impact of glycan-microdomains of the HIV-1 Env glycan shield$718,601
R01 · FY2025 · AI
Molecular Basis of Pathogenicity of IgA1-containing Immune Complexes$633,372
R01 · FY2025 · DK · contact PI
Defining the impact of glycan-microdomains of the HIV-1 Env glycan shield$718,601
R01 · FY2024 · AI
Molecular Basis of Pathogenicity of IgA1-containing Immune Complexes$643,133
R01 · FY2024 · DK · contact PI
Elucidating IgA nephropathy through Genetic Studies of IgA1 Glycosylation$638,560
R01 · FY2024 · DK
Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease$515,750
R01 · FY2024 · AI
Defining the impact of glycan-microdomains of the HIV-1 Env glycan shield$718,601
R01 · FY2023 · AI
Elucidating IgA nephropathy through Genetic Studies of IgA1 Glycosylation$665,167
R01 · FY2023 · DK
Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease$515,750
R01 · FY2023 · AI
Molecular Basis of Pathogenicity of IgA1-containing Immune Complexes$401,493
R01 · FY2023 · DK · contact PI
Defining the impact of glycan-microdomains of the HIV-1 Env glycan shield$718,601
R01 · FY2022 · AI
Elucidating IgA nephropathy through Genetic Studies of IgA1 Glycosylation$665,167
R01 · FY2022 · DK
Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease$515,750
R01 · FY2022 · AI
Molecular Basis of Pathogenicity of IgA1-containing Immune Complexes$401,493
R01 · FY2022 · DK · contact PI
Defining the impact of glycan-microdomains of the HIV-1 Env glycan shield$718,601
R01 · FY2021 · AI
Elucidating IgA nephropathy through Genetic Studies of IgA1 Glycosylation$696,167
R01 · FY2021 · DK
Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease$515,750
R01 · FY2021 · AI
Molecular Basis of Pathogenicity of IgA1-containing Immune Complexes$401,493
R01 · FY2021 · DK · contact PI
Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease$515,750
R01 · FY2020 · AI
Molecular Basis of Pathogenicity of IgA1-containing Immune Complexes$406,783
R01 · FY2020 · DK · contact PI
Molecular Basis of Pathogenicity of IgA1-containing Immune Complexes$408,329
R01 · FY2019 · DK · contact PI
Elucidating IgA nephropathy through Genetic Studies of IgA1 Glycosylation$661,306
R01 · FY2018 · DK
Elucidating IgA nephropathy through Genetic Studies of IgA1 Glycosylation$661,306
R01 · FY2017 · DK
Elucidating IgA nephropathy through Genetic Studies of IgA1 Glycosylation$661,306
R01 · FY2016 · DK
IgA Nephropathy: Interventions with Generation of Nephritogenic Immune Complexes$315,383
R01 · FY2016 · DK
Molecular Basis of Pathogenicity of IgA1-containing Immune Complexes$219,750
R01 · FY2016 · DK · contact PI
Elucidating IgA nephropathy through Genetic Studies of IgA1 Glycosylation$661,631
R01 · FY2015 · DK
IgA Nephropathy: Interventions with Generation of Nephritogenic Immune Complexes$346,150
R01 · FY2015 · DK
Molecular Basis of Pathogenicity of IgA1-containing Immune Complexes$219,750
R01 · FY2015 · DK · contact PI
Elucidating IgA nephropathy through Genetic Studies of IgA1 Glycosylation$702,756
R01 · FY2014 · DK
IgA Nephropathy: Interventions with Generation of Nephritogenic Immune Complexes$331,839
R01 · FY2014 · DK
Molecular Basis of Pathogenicity of IgA1-containing Immune Complexes$219,750
R01 · FY2014 · DK · contact PI
Molecular Basis of Pathogenicity of IgA1-containing Immune Complexes$219,750
R01 · FY2013 · DK · contact PI
Elucidating IgA Nephropathy through Genetic Studies of IgA1 Glycosylation$607,908
R01 · FY2012 · DK · contact PI
Molecular Basis of Pathogenicity of IgA1-containing Immune Complexes$92,295
R56 · FY2012 · DK · contact PI
Elucidating IgA Nephropathy through Genetic Studies of IgA1 Glycosylation$616,765
R01 · FY2011 · DK · contact PI
Molecular Basis of Pathogenicity of 1gA1 - containing Immune Complexes$236,627
R01 · FY2011 · DK · contact PI
New Animal Model for Studies of mucosal Immunity and IgA Nephropathy$217,553
R21 · FY2011 · DK · contact PI
Elucidating IgA Nephropathy through Genetic Studies of IgA1 Glycosylation$714,626
R01 · FY2010 · DK · contact PI
Molecular Basis of Pathogenicity of 1gA1 - containing Immune Complexes$246,188
R01 · FY2010 · DK · contact PI
Urinary Polypeptide Biomarkers of IgA Nephropathy$183,125
R21 · FY2010 · DK · contact PI
New Animal Model for Studies of mucosal Immunity and IgA Nephropathy$183,125
R21 · FY2010 · DK · contact PI
Elucidating IgA Nephropathy through Genetic Studies of IgA1 Glycosylation$756,774
R01 · FY2009 · DK · contact PI
Molecular Basis of Pathogenicity of 1gA1 - containing Immune Complexes$248,675
R01 · FY2009 · DK · contact PI
Urinary Polypeptide Biomarkers of IgA Nephropathy$219,500
R21 · FY2009 · DK · contact PI
IgA-secreting B cell lines: a novel tool for studies of IgA nephropathy$181,250
R21 · FY2009 · DK · contact PI
Molecular Basis of Pathogenicity of 1gA1 - containing Immune Complexes$1,460
R01 · FY2009 · DK · contact PI
Molecular Basis of Pathogenicity of 1gA1 - containing Immune Complexes$248,675
R01 · FY2008 · DK · contact PI
IgA-secreting B cell lines: a novel tool for studies of IgA nephropathy$217,500
R21 · FY2008 · DK · contact PI
Molecular Basis of Pathogenicity of 1gA1 - containing Immune Complexes$253,750
R01 · FY2007 · DK · contact PI
Immune Complexes and Mesangial Cells in IGA Nephropathy$0
P01 · FY2002 · DK